Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Tyrosine kinase inhibitors in...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia

Bibliographic Details
Published in:Haematologica
Main Authors: Veronica Leoni, Andrea Biondi
Format: Article
Language:English
Published: Ferrata Storti Foundation 2015-03-01
Online Access:https://haematologica.org/article/view/7299
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/7299

Similar Items

  • BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
    by: Gunnar Cario, et al.
    Published: (2020-05-01)
  • Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era
    by: Ting Shi, et al.
    Published: (2020-11-01)
  • New ABL1 Kinase Domain Mutations in BCR::ABL1‐Positive Acute Lymphoblastic Leukemia
    by: Zixuan Li, et al.
    Published: (2024-10-01)
  • BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors
    by: Ja Min Byun, et al.
    Published: (2017-05-01)
  • Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias
    by: Jing-Ying Zou, et al.
    Published: (2023-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs